These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 22269856)
21. The prevalence of urinary tract infection, or urosepsis following transrectal ultrasound-guided prostate biopsy in a subset of the Saudi population and patterns of susceptibility to flouroquinolones. AlKhateeb SS; AlShammari NA; AlZughaibi MA; Ghazwani YG; Alrabeeah KA; Albqami NM Saudi Med J; 2016 Aug; 37(8):860-3. PubMed ID: 27464862 [TBL] [Abstract][Full Text] [Related]
22. Baseline prevalence of antimicrobial resistance and subsequent infection following prostate biopsy using empirical or altered prophylaxis: A bias-adjusted meta-analysis. Roberts MJ; Williamson DA; Hadway P; Doi SA; Gardiner RA; Paterson DL Int J Antimicrob Agents; 2014 Apr; 43(4):301-9. PubMed ID: 24630305 [TBL] [Abstract][Full Text] [Related]
24. An antimicrobial prophylaxis protocol using rectal swab cultures for transrectal prostate biopsy. Summers SJ; Patel DP; Hamilton BD; Presson AP; Fisher MA; Lowrance WT; Southwick AW World J Urol; 2015 Dec; 33(12):2001-7. PubMed ID: 25935330 [TBL] [Abstract][Full Text] [Related]
25. Comparative Effectiveness of Single versus Combination Antibiotic Prophylaxis for Infections after Transrectal Prostate Biopsy. Marino K; Parlee A; Orlando R; Lerner L; Strymish J; Gupta K Antimicrob Agents Chemother; 2015 Dec; 59(12):7273-5. PubMed ID: 26369958 [TBL] [Abstract][Full Text] [Related]
26. A Prospective Randomized Trial Comparing a Combined Regimen of Amikacin and Levofloxacin to Levofloxacin Alone as Prophylaxis in Transrectal Prostate Needle Biopsy. Miyazaki Y; Akamatsu S; Kanamaru S; Kamiyama Y; Sengiku A; Iguchi R; Sano T; Takahashi A; Ito M; Takenawa J; Ito N; Ogura K Urol J; 2016 Mar; 13(1):2533-40. PubMed ID: 26945658 [TBL] [Abstract][Full Text] [Related]
27. A prospective randomized comparative study of targeted versus empirical prophylactic antibiotics in the prevention of infective complications following transrectal ultrasound-guided prostate biopsy. Doherty AF; Ikuerowo SO; Jeje EA; Ibrahim NA; Ojongbede OL; Mutiu WB; Omisanjo OA; Abolarinwa AA Ann Afr Med; 2019; 18(3):132-137. PubMed ID: 31417013 [TBL] [Abstract][Full Text] [Related]
28. Fluoroquinolone-based antimicrobial prophylaxis in patients undergoing transrectal ultrasound-guided prostate biopsy. Sieczkowski M; Gibas A; Bronk M; Matuszewski M Eur J Clin Microbiol Infect Dis; 2015 Sep; 34(9):1815-21. PubMed ID: 26048634 [TBL] [Abstract][Full Text] [Related]
29. Antimicrobial prophylaxis protocol based on rectal swab culture before prostate biopsy to prevent infectious complications: a prospective randomized comparative study. Bouzouita A; Rehaiem A; Saadi A; Zaghbib S; Chakroun M; Ayed H; Ferjani A; Derouiche A; Boubaker IB; Slama MRB Int Urol Nephrol; 2024 Aug; 56(8):2495-2502. PubMed ID: 38448785 [TBL] [Abstract][Full Text] [Related]
30. Fluoroquinolone-resistant E. coli in intestinal flora of patients undergoing transrectal ultrasound-guided prostate biopsy--should we reassess our practices for antibiotic prophylaxis? Steensels D; Slabbaert K; De Wever L; Vermeersch P; Van Poppel H; Verhaegen J Clin Microbiol Infect; 2012 Jun; 18(6):575-81. PubMed ID: 21958149 [TBL] [Abstract][Full Text] [Related]
31. [Clinical significance of antibiotic prophylaxis for transrectal prostate biopsy]. Yang L; Hu J; Wei H; Wang L; Zhong H Zhonghua Wai Ke Za Zhi; 2001 Dec; 39(12):940-2. PubMed ID: 16201177 [TBL] [Abstract][Full Text] [Related]
32. Ertapenem prophylaxis reduces sepsis after transrectal biopsy of the prostate. Losco G; Studd R; Blackmore T BJU Int; 2014 Mar; 113 Suppl 2():69-72. PubMed ID: 24894854 [TBL] [Abstract][Full Text] [Related]
33. Prevalence and predictive factors of harboring fluoroquinolone-resistant and extended-spectrum β-lactamase-producing rectal flora in Hong Kong Chinese men undergoing transrectal ultrasound-guided prostate biopsy. Tsu JH; Ma WK; Chan WK; Lam BH; To KC; To WK; Ng TK; Liu PL; Cheung FK; Yiu MK Urology; 2015 Jan; 85(1):15-21. PubMed ID: 25444632 [TBL] [Abstract][Full Text] [Related]
34. Targeted antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy during active surveillance: Effect on hospitalization. Cheung C; Patel HD; Landis P; Carter HB; Han M Urol Oncol; 2018 Apr; 36(4):158.e7-158.e12. PubMed ID: 29288004 [TBL] [Abstract][Full Text] [Related]
35. Routine Ertapenem Prophylaxis for Transrectal Ultrasound Guided Prostate Biopsy does Not Select for Carbapenem Resistant Organisms: A Prospective Cohort Study. Bloomfield MG; Page MJ; McLachlan AG; Studd RC; Blackmore TK J Urol; 2017 Aug; 198(2):362-368. PubMed ID: 28288838 [TBL] [Abstract][Full Text] [Related]
36. Reduction in hospital admissions with the addition of prophylactic intramuscular ceftriaxone before transrectal ultrasonography-guided prostate biopsies. Luong B; Danforth T; Visnjevac O; Suraf M; Duff M; Chevli KK Urology; 2015 Mar; 85(3):511-6. PubMed ID: 25596154 [TBL] [Abstract][Full Text] [Related]
37. A single dose of meropenem is superior to ciprofloxacin in preventing infections after transrectal ultrasound-guided prostate biopsies in the era of quinolone resistance. Samarinas M; Dimitropoulos K; Zachos I; Gravas S; Karatzas A; Tzortzis V World J Urol; 2016 Nov; 34(11):1555-1559. PubMed ID: 26951136 [TBL] [Abstract][Full Text] [Related]
38. Predictors of Infectious Complications after Targeted Prophylaxis for Prostate Needle Biopsy. Papagiannopoulos D; Abern M; Wilson N; O'Block N; Raff L; Coogan C; Latchamsetty KC J Urol; 2018 Jan; 199(1):155-160. PubMed ID: 28807644 [TBL] [Abstract][Full Text] [Related]
39. Sepsis due to fluoroquinolone-resistant Escherichia coli after transrectal ultrasound-guided prostate needle biopsy. Young JL; Liss MA; Szabo RJ Urology; 2009 Aug; 74(2):332-8. PubMed ID: 19464041 [TBL] [Abstract][Full Text] [Related]